Early postoperative use of unfractionated heparin or enoxaparin is associated with increased surgical re-exploration for bleeding

Annals of Thoracic Surgery

Volumn 80, Issue 2, 2005, Pages 518-522

  Jones, Heath U ^b   Muhlestein, Joseph B ^a   Jones, Kent W ^b   Renlund, Dale G ^b   Bair, Tami L ^b   Bunch, T Jared ^b   Horne, Benjamin D ^b   Lappé, Donald L ^b   Anderson, Jeffrey L ^b   Doty, Donald B ^b  

^a LDS HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; OPEN HEART SURGERY; PATIENT INFORMATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; REOPERATION; RISK ASSESSMENT; SEX DIFFERENCE; SURGICAL PATIENT; SURGICAL RISK; TREATMENT INDICATION;

AGED; ANTICOAGULANTS; CARDIAC SURGICAL PROCEDURES; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; REOPERATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 22544431916     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2005.02.009     Document Type: Article

References (20)

1. L. Shore-Lesserson, G.P. Gravlee Anticoagulation for cardiopulmonary bypass G.P. Gravlee R.F. Davis M. Kurusz J.R. Utley Cardiopulmonary bypass 2000 Lippincott Williams & Wilkins Philadelphia 436
2. L.A. Wolk, R.F. Wilson, M. Burdick Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass Am Surg 51 1985 309
3. G.W. Albers, J.E. Dalen, A. Laupacis, W.J. Manning, P. Petersen, D.E. Singer Antithrombotic therapy in atrial fibrillation Chest 119 Suppl 1 2001 194S 206S
4. P.D. Stein, J.S. Alpert, H.I. Bussey, J.E. Dalen, A.G. Turpie Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves Chest 119 Suppl 1 2001 220S 227S
5. G. Kouvaras, G. Chronopoulos, G. Soufras The effects of long-term antithrombotic treatment on left ventricular thrombi in patients after an acute myocardial infarction Am Heart J 119 1 1990 73 78
6. T.M. Hyers, G. Agnelli, R.D. Hull Antithrombotic therapy for venous thromboembolic disease Chest 119 Suppl 1 2001 176S 193S
7. J.I. Weitz Low-molecular-weight heparins N Engl J Med 337 21 1997 688 698
8. M. Cohen, C. Demers, E.P. Gurfinkel A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group N Engl J Med 337 7 1997 447 452
9. E.M. Antman, M. Cohen, D. Radley Assessment of the treatment effect of enoxaparin for unstable angina/non-Q-wave myocardial infarction. TIMI 11B-ESSENCE meta-analysis Circulation 100 15 1999 1602 1608
10. E.M. Antman, C.H. McCabe, E.P. Gurfinkel Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial Circulation 100 15 1999 1593 1601
11. G. Merli, T.E. Spiro, C.G. Olsson The Enoxaparin Clinical Trial Group Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease Ann Intern Med 134 3 2001 191 202
12. H.U. Jones, J.B. Muhlestein, K.W. Jones Pre-operative use of enoxaparin compared to unfractionated heparin increases the incidence of re-exploration for post-operative bleeding after open heart surgery in patients who present with an acute coronary syndrome Circulation 106 Suppl I 2002 I19 I22
13. R. Cartier, D. Robitaille Thrombotic complications in beating heart operations J Thorac Cardiovasc Surg 121 5 2001 920 922
14. E.K. Heres, J.C. Horrow, G.P. Gravlee A dose-determining trial of heparinase-I (Neutralase) for heparin neutralization in coronary artery surgery Anesth Analg 93 6 2001 1446 1452
15. T.L. Bauer, G. Arepally, B.A. Konkle Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery Circulation 95 5 1997 1242 1246
16. A.K. Ganjoo, M.G. Harloff, W.D. Johnson Cardiopulmonary bypass for heparin-induced thrombocytopenia management with a heparin-bonded circuit and enoxaparin J Thorac Cardiovasc Surg 112 5 1996 1390 1392
17. D. Robitaille, J.R. Leclerc, R. Laberge Cardiopulmonary bypass with a low-molecular-weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia J Thorac Cardiovasc Surg 103 3 1992 597 599
18. W.D. Boyd, N.D. Desai, D.F. Del Rizzo Off-pump surgery decreases postoperative complications and resource utilization in the elderly Ann Thorac Surg 68 4 1999 1490 1493
19. M. Zenati, T.M. Domit, M. Saul Resource utilization for minimally invasive direct and standard coronary artery bypass grafting Ann Thorac Surg 63 Suppl 6 1997 S84 S87
20. Anonymous Dose-ranging trial of enoxaparin for unstable angina results of TIMI 11A. The Thrombolysis in Myocardial Infarction (TIMI) 11A Trial Investigators J Am Coll Cardiol 29 7 1997 1474 1482